Market Overview

Tesaro Comes Roaring Back From Much Lower Open

Related TSRO
Benzinga's Top Upgrades, Downgrades For November 15, 2017
57 Biggest Movers From Yesterday
Tesaro (TSRO) Presents At Guggenheim Securities 5th Annual Boston Healthcare Conference 2017 - Slideshow (Seeking Alpha)
Related CLVS
Credit Suisse Adjusts Its Top Picks List In A Record-Breaking Market
Benzinga's Top Upgrades, Downgrades For October 23, 2017

TESARO Inc (NASDAQ: TSRO) shares are trading lower by $2.31 at $142 in Monday's session. The catalyst for the much lower open was the announcement that rival Clovis Oncology Inc (NASDAQ: CLVS) reported positive results for its cancer, which is in direct competition with a treatment Tesaro has in the pipeline.

After a much lower open, it continued in that direction before bottoming in the first minute of the session at $129.04 and embarked on a vicious rebound. So far, the ensuing rally has taken the issue beyond the lower-end of Friday's range ($142.63) as $143.30 stands as the current high of the day. If the rally continues beyond that high, there may be additional resistance at the pair of closes from Thursday ($144.23) and Friday ($144.31).

Posted-In: Biotech News Technicals Intraday Update Movers Trading Ideas General


Related Articles (CLVS + TSRO)

View Comments and Join the Discussion!

Partner Center